BioScrip Schedules Release of Fourth Quarter and Full Year 2017 Financial Results and Conference Call
23 February 2018 - 12:00AM
Business Wire
BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the
largest independent national provider of infusion and home care
management solutions, today announced that the Company will issue
its financial results press release for the fourth quarter and full
year ended December 31, 2017 on Thursday, March 8, 2018 before the
opening of the U.S. financial markets.
Daniel E. Greenleaf, President and Chief Executive Officer, and
Stephen Deitsch, Senior Vice President, Chief Financial Officer and
Treasurer, will host a conference call as follows:
Date March 8, 2018 Time 9:00 a.m. ET Toll free (U.S.)
(877) 423-9820 International (201) 493-6749 Webcast (live and
replay)
www.investorcalendar.com/event/26127
or
www.bioscrip.com
The online replay will be available within two hours of the
call’s completion in the Investor Relations section of BioScrip’s
web site at: www.bioscrip.com.
About BioScrip, Inc.
BioScrip, Inc. is the largest independent national provider of
infusion and home care management solutions, with approximately
2,200 teammates and nearly 80 service locations across the U.S.
BioScrip partners with physicians, hospital systems, payors,
pharmaceutical manufacturers and skilled nursing facilities to
provide patients access to post-acute care services. BioScrip
operates with a commitment to bring customer-focused pharmacy and
related healthcare infusion therapy services into the home or
alternate-site setting. By collaborating with the full spectrum of
healthcare professionals and the patient, BioScrip provides
cost-effective care that is driven by clinical excellence, customer
service, and values that promote positive outcomes and an enhanced
quality of life for those it serves.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180222005481/en/
Investors:BioScrip,
Inc.Stephen Deitsch, 720-697-5200Chief Financial Officer &
Treasurerstephen.deitsch@bioscrip.comorThe Equity GroupKalle Ahl,
CFA, 212-836-9614kahl@equityny.com
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Apr 2024 to May 2024
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From May 2023 to May 2024